Authors: Cigdem Altan, Hülya Güngel, Merih Gül, Hakan Eren, Tanýl Gürsel, Eyüp Durgut, Istanbul, Turkey

Advantages / Purpose:

To present the treatment approaches to cases with central serous chorioretinopathy (CSC).

Methods:

Twenty-six eyes of 25 patients who were diagnosed as CSC and followed between May 2008 and February 2009 were included in the study. Demographic data, visual acuity and macular thickness, management and recovery time were recorded. All patients received topical Ketorolac tromethamine and oral acetozolamide and followed-up monthly. Patients who had subretinal fluid with optical coherence tomography after sixth months were applied photodynamic therapy (PDT) or laser photocoagulation (LPC).

Effectiveness / Safety:

There were 20 males and 5 females. Their mean age was 44,9±13,9 years. Visual acuity at presentation ranged from 0,07 to 1.0 (Snellen). The mean macular thickness was 381,5 μ ±130,1μ at presentation, 264,5 μ ±110,7 μ at last visit. The average visual acuity improved from 0,54 at presentation to 0,74 at last visit. 19 patients recovered with medical therapy in average 4,4±1,4 months. Laser photocoagulation was applied to 1 patient with persistent focal leakage and photodynamic therapy (PDT) was performed to 6 patients with diffuse leakage. Subretinal fluid was reabsorbed following PDT and laser photocoagulation within an average of 0,75±0,29 months.

Take home message:

Laser photocoagulation and PDT are beneficial in patients who do not respond to medical therapy in six months. These treatment modalities may shorten the recovery time in patients with chronic CSC.